Pharmacy and Therapeutics Community Wire - "National Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer Community"

New York, NY
 – May 22, 2017  –– 

ESARO, Inc., an oncology-focused biopharmaceutical company, today announced the results of the Our Way Forward survey - a national survey created with input from leading ovarian cancer advocacy groups and healthcare providers to better understand the unmet education and support needs of the advanced ovarian cancer community. "Facing ovarian cancer can be extremely stressful and anxiety-provoking," said Stephanie V. Blank, MD, professor in the division of gynecologic oncology, department of obstetrics, gynecology and reproductive science, Icahn School of Medicine at Mount Sinai, and director of Women's Health, Mount Sinai Downtown-Chelsea Center. "We can support survivors by better understanding their needs and perspectives, and how these evolve with time."
Stephanie V. Blank, MD, Professor in the Division of Gynecologic Oncology, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, and Director of Women's Health, Mount Sinai Downtown-Chelsea Center

Learn more